Eli Lilly and Co (MIC:LLY-RM) OCF Margin %: 26.94% (As of Mar. 2026) — Near Median


What is Eli Lilly and Co OCF Margin %?

Eli Lilly and Co MIC:LLY-RM 98 OCF Margin % is 26.94% as of Mar. 2026, which is 5% above its 10-year median of 25.75. GuruFocus rates MIC:LLY-RM with a GF Score™ of 98/100. The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Eli Lilly and Co ranks better than 91.21% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Eli Lilly and Co's Cash Flow from Operations for the three months ended in Mar. 2026 was ₽433,514.25 Mil. Eli Lilly and Co's Revenue for the three months ended in Mar. 2026 was ₽1,609,440.94 Mil. Therefore, Eli Lilly and Co's OCF Margin % for the quarter that ended in Mar. 2026 was 26.94%.

As of today, Eli Lilly and Co's current OCF Yield % is 1.90%.

The historical rank and industry rank for Eli Lilly and Co's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Eli Lilly and Co was 28.11%. The lowest was 12.43%. And the median was 25.75%.

MIC:LLY-RM's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.985
* Ranked among companies with meaningful OCF Margin % only.

Eli Lilly and Co OCF Margin % Related Terms

Eli Lilly and Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co OCF Margin % Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.01 26.58 12.43 19.58 25.80

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.09 19.84 50.20 16.71 26.94

Eli Lilly and Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Eli Lilly and Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=1336569.624/5181482.87
=25.80 %

Eli Lilly and Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=433514.246/1609440.944
=26.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 26.94% mean?
Eli Lilly and Co (MIC:LLY-RM) has a OCF Margin % of 26.94% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eli Lilly and Co and its competitors. This is near median its historical median of 25.75. Over the past decade, Eli Lilly and Co's OCF Margin % has ranged from 12.43 to 28.11. According to the industry distribution chart, Eli Lilly and Co ranks #84 out of 956 companies in the Drug Manufacturers industry, placing it in the top 8.8%.
Is Eli Lilly and Co's OCF Margin % too high?
Eli Lilly and Co's current OCF Margin % of 26.94% is near median its 10-year median of 25.75. Over the past 10 years, this metric has ranged from a low of 12.43 to a high of 28.11. The Drug Manufacturers industry median OCF Margin % is 9.99. Eli Lilly and Co's value of 26.94% is 169.8% above this industry median. Based on the distribution chart, Eli Lilly and Co ranks #84 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Eli Lilly and Co has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's OCF Margin % compare to JNJ and ABBV?
According to the Drug Manufacturers industry distribution chart, Eli Lilly and Co ranks #84 out of 956 companies for OCF Margin %. This places Eli Lilly and Co in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.99. Eli Lilly and Co's value of 26.94% is 169.8% above this benchmark. Historically, Eli Lilly and Co's own OCF Margin % has ranged from 12.43 to 28.11 over the past decade. While the company's 10-year median is 25.75 vs. the industry median of 9.99, Eli Lilly and Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eli Lilly and Co's current OCF Margin % of 26.94% is 169.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eli Lilly and Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eli Lilly and Co's current OCF Margin % is 26.94%, which is near median its own 10-year median of 25.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Eli Lilly and Co (MIC:LLY-RM) has a current OCF Margin % of 26.94%. The current OCF Margin % is 26.94%, which is near median its 10-year median of 25.75 and 169.8% above the Drug Manufacturers industry median of 9.99. Eli Lilly and Co's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Eli Lilly and Co (MIC:LLY-RM), the current OCF Margin % is 26.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.